ARCHIVES

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Designates Zometa For Priority Review.

November 30, 2001

NCI document says 2015 goal formed in 2001, long before announcement.

February 13, 2004

Army of Women, caBIG To Collaborate.

August 7, 2009

Intergroup 5-FU/Levamisole Study Positive Enough Now To End Untreated Control Arms

September 22, 1989

NCI To Fund Partnerships Between Cancer Centers and Minority Institutions

November 12, 1999

Cancer Patients Who Die In Hospital Or ICU Have Worse QOL; Caregivers Affected, Too

September 24, 2010